Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) EBITDA Margin (2019 - 2025)

Korro Bio (KRRO) has disclosed EBITDA Margin for 5 consecutive years, with 1653.58% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA Margin changed N/A year-over-year to 1653.58%, compared with a TTM value of 1204.41% through Sep 2025, changed N/A, and an annual FY2024 reading of 3668.56%, changed N/A over the prior year.
  • EBITDA Margin was 1653.58% for Q3 2025 at Korro Bio, up from 1771.03% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 7072.54% in Q1 2023 and bottomed at 1771.03% in Q2 2025.
  • Average EBITDA Margin over 4 years is 166.25%, with a median of 917.29% recorded in 2025.
  • Peak annual rise in EBITDA Margin hit -11291bps in 2021, while the deepest fall reached -35644bps in 2021.
  • Year by year, EBITDA Margin stood at 185.65% in 2021, then surged by 3910bps to 7072.54% in 2023, then tumbled by -113bps to 946.94% in 2024, then plummeted by -75bps to 1653.58% in 2025.
  • Business Quant data shows EBITDA Margin for KRRO at 1653.58% in Q3 2025, 1771.03% in Q2 2025, and 917.29% in Q1 2025.